Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AZD5863 |
Trade Name | |
Synonyms | AZD 5863|AZD-5863 |
Drug Descriptions |
AZD5863 is a bispecific T-cell engager targeting CLDN18.2 and CD3, which potentially induces T-cell dependent cellular cytotoxicity and tumor growth inhibition (J ImmunoTherapy Cancer 2023;11 (Suppl_1):1169). |
DrugClasses | CD3 Antibody 99 CLDN18.2 Antibody 19 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AZD5863 | AZD5863 | 0 | 1 |